Outcomes of Cannabis Use During Pregnancy Within the American Association of Birth Centers Perinatal Data Registry 2007-2020

Joseph-Lemon, Lodz; Thompson, Heather; Verostick, Lori; Oura, Haley Shizuka; Jolles, Diana

doi:10.1097/jpn.0000000000000668

Cited by 3 publications

(1 citation statement)

References 45 publications

(96 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is some evidence to suggest that the use of cannabis can be associated with stroke and atrial fibrillation, can alter the brain by reducing glutamate, decreasing the hippocampal volume and causing poorer global functioning, ( 62 ) and when consumed by pregnant users can increase the risk of low-birth-weight and other neonatal complications ( 63 ). In a 2021 Danish study of 2,841 users of cannabis for medicinal purposes, 85.5% reported that they considered the side effects of prescription drug use to be worse than those of cannabis ( 64 ).…”

Section: Resultsmentioning

confidence: 99%

The experiences of endometriosis patients with diagnosis and treatment in New Zealand

Ellis

Munro

Wood

2022

Front. Glob. Womens Health

View full text Add to dashboard Cite

Endometriosis is a chronically painful, invasive, inflammatory disease, with limited treatment options and long delays to diagnosis, which impacts 10% of females in New Zealand.IntroductionAs part of a larger group discussion study, this paper covers three themes associated with endometriosis patient experiences: intensity of pain, diagnostic tool shortcomings and perspectives of treatment options.Materials and methodsThe goal of this research was the inclusion of patient voices to guide research priorities. In early 2022, 50 New Zealand endometriosis patients participated in anonymous, asynchronous, text-based group discussions on the VisionsLive platform. The patients ranged in age from 18–48. The patients answered 50 questions, 23 text-based and 27 quantitative, and then took part in online group discussions.Results and discussionThe average age of symptom onset was 15.3 years, while the average delay from symptom onset to a working or surgically confirmed diagnosis was 7.91 years. The top five reported symptoms within the cohort were pain-based, and the participants discussed the many impacts of this pain on their work and education. The four main diagnostic tools employed on this cohort were abdominal ultrasound (72%), transvaginal ultrasound (68%), laparoscopy (82%) and sharing their symptom history with a medical practitioner (88%). The most common emotions patients experienced following receiving a diagnosis of endometriosis were relief (86%), feeling overwhelmed (54%), and anger (32%). The main treatments offered to this cohort were pain relief (96%), laparoscopic surgery (84%) and the combined oral contraceptive pill (80%). Of these three treatments, only laparoscopic surgery was viewed positively by the majority of users, with 67% considering laparoscopy an effective treatment, compared to 46% of users for pain relief, and 25% of users for the combined oral contraceptive pill.ConclusionsGathering the voice of patients revealed that long delays to diagnosis and dismissal by medical practitioners frequently manifests as a reaction of relief by patients once diagnosed. Results also showed treatment options such as pain relief and hormonal medications were often considered ineffective, but were routinely offered as the first, or only, options for patients. It is therefore important that both quicker routes to diagnosis and more effective treatment options be developed.

show abstract

Section: Resultsmentioning

confidence: 99%

The experiences of endometriosis patients with diagnosis and treatment in New Zealand

Ellis

Munro

Wood

2022

Front. Glob. Womens Health

View full text Add to dashboard Cite

show abstract

Prenatal Exposure to Cannabis: Effects on Childhood Obesity and Cardiometabolic Health

Moore

2024

Curr Obes Rep

View full text Add to dashboard Cite

Purpose of Review To consolidate information on the obesogenic and cardiometabolic effects of prenatal exposure to cannabis. Recent Findings A PubMed search strategy updated from January 1, 2014, through 14 June 2023, produced a total of 47 epidemiologic studies and 12 animal studies. Prenatal exposure to cannabis is consistently associated with small for gestational age and low birth weight. After birth, these offspring gain weight rapidly and have increased adiposity and higher glucose (fat mass percentage) in childhood. More preclinical and prospective studies are needed to deepen our understanding of whether these associations vary by sex, dose, timing, and composition of cannabis (e.g., ratio of delta-Δ9-tetrahydrocannabinol [Δ9-THC] to cannabidiol [CBD]). Addressing these gaps may help to solidify causality and identify intervention strategies. Summary Based on the available data, clinicians and public health officials should continue to caution against cannabis use during pregnancy to limit its potential obesogenic and adverse cardiometabolic effects on the offspring.

show abstract

Predictors for cannabis cessation during pregnancy: a 10-year cohort study

Brik,

Sandonis,

Cabeza Oliver

et al. 2024

Journal of Psychosomatic Obstetrics & Gynecology

View full text Add to dashboard Cite

Outcomes of Cannabis Use During Pregnancy Within the American Association of Birth Centers Perinatal Data Registry 2007-2020

Cited by 3 publications

References 45 publications

The experiences of endometriosis patients with diagnosis and treatment in New Zealand

The experiences of endometriosis patients with diagnosis and treatment in New Zealand

Prenatal Exposure to Cannabis: Effects on Childhood Obesity and Cardiometabolic Health

Predictors for cannabis cessation during pregnancy: a 10-year cohort study

Contact Info

Product

Resources

About